Literature DB >> 1211919

Prevention of herpes keratoconjunctivitis in rabbits by silver sulfadiazine.

T W Chang, L Weinstein.   

Abstract

Silver sulfadiazine, at a concentration of 10 mug/ml when applied immediately after infection by Herpesvirus hominis, prevented the development of acute herpetic keratoconjunctivitis in rabbits. The efficacy was inversely related to the size of inoculum. Subclinical infections were observed in the drug-treated eyes.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1211919      PMCID： PMC429446          DOI： 10.1128/AAC.8.6.677

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  In vitro activity of silver sulfadiazine against Herpesvirus hominis.

Authors:  L Weinstein
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

2.  Antifungal activity of silver sulphadiazine.

Authors:  T J Wlodkowski; H S Rosenkranz
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

3.  The successful control of burn wound sepsis.

Authors:  R B Lindberg; J A Moncrief; W E Switzer; S E Order; W Mills
Journal:  J Trauma       Date:  1965-09

4.  Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.

Authors:  C L Fox
Journal:  Arch Surg       Date:  1968-02

5.  Inactivation of Treponema pallidum by silver sulfadiazine.

Authors:  T W Chang; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

6.  Inactivation of Herpesvirus hominis types 1 and 2 by silver nitrate in vitro and in vivo.

Authors:  V R Coleman; J Wilkie; W E Levinson; T Stevens; E Jawetz
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191
  6 in total
  2 in total

1.  Ecofriendly production of silver nanoparticles using Candida utilis and its mechanistic action against pathogenic microorganisms.

Authors:  Shailesh R Waghmare; Mustopa N Mulla; Suryakant R Marathe; Kailas D Sonawane
Journal:  3 Biotech       Date:  2014-01-24       Impact factor: 2.406

2.  Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder.

Authors:  Ruiling Luan; Zhiling Mu; Fang Yue; Shaoying He
Journal:  Front Psychiatry       Date:  2017-11-13       Impact factor: 4.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.